Western Balkans citizens legally resident in EU equal to 14% of region’s population
International Ice Hockey Federation (IIHF) has stripped Belarus of the right to hold the World Championship this year
Alexei Navalny arrested on arrival as he returns home
LONG READ: The oligarch problem
MOSCOW BLOG: Has Navalny started a revolution?
Russia's biggest demonstrations since 2011 in protest against Navalny jailing
Opposition activist Navalny's call for mass protests a success as thousands take to the streets across Russia
Russia's National Welfare Fund accounts for almost 12% of GDP
NBU keeps key policy rate at 6%, worsens CPI outlook
Western Balkans and Ukraine urged to scrutinise coal subsidies
Oligarchs trying to derail Ukraine’s privatisation programme, warns the head of Ukraine’s State Property Fund
VISEGRAD BLOG: Central Europe's populists need a new strategy for Biden
OUTLOOK 2021 Lithuania
EBRD says loan to Estonia’s controversial Porto Franco project was never disbursed
Czech MPs pass protectionist food law in violation of EU rules
M&A in Central and Eastern Europe fell 16% in value in 2020, says CMS report
Hungarian vehicle makers hit by supply chain shortage
COVID-19 and Trump’s indifference helped human rights abusers in 2020
OUTLOOK 2021 Poland
OUTLOOK 2021 Slovakia
BRICKS & MORTAR: Rosier future beckons for CEE retailers after year of change and disruption
FDI inflows to CEE down 58% in 1H20 but rebound expected
BALKAN BLOG: Superstition and resentment surround vaccination plans
Albania needs reforms for e-commerce to thrive, says World Bank
BALKAN BLOG: US approach to switch from quick-fix dealmaking to experience and cooperation
Bosnia's exports in 2020 amounted to BAM10.5bn, trade deficit to BAM6.3bn
Retailers and restaurant owners threaten protests in Bulgaria if reopening is delayed
Bulgaria's Biodit first company to IPO on new BEAM market
Bulgaria’s government considers gradual easing of COVID-related restrictions
Spring lockdown caused spike in online transactions in Croatia
ING: Growth in the Balkans: from zero to hero again?
Labour demand down 28% y/y in Croatia in 2020
OUTLOOK 2021 Moldova
Storming parliaments: New Europe's greatest hits
World Bank revises projection for Moldova’s 2020 GDP decline to 7.2%
North Macedonia plans to cut personal income tax in IT sector to zero in 2023
Romania government to pursue “ambitious” timetable for justice reforms
Private finance mobilised by development banks up 9% to $175bn in 2019
OUTLOOK 2021 Romania
OUTLOOK 2021 Slovenia
Slovenia’s opposition files no-confidence motion against Jansa cabinet
Slovenia’s government to release funds to news agency STA after EU pressure
UK Moneyhub picks Slovenia for post-Brexit European base
D’S Damat franchise deals ‘show Turkey’s hard-pressed mall operators becoming their own tenants’
Turkey’s benchmark rate held as concerns over faltering recovery come to fore
Turkish lira breaches HSBC’s stop-loss, Turkey ETF signalling outflows
CAUCASUS BLOG : What can Biden offer the Caucasus and Stans, all but forgotten about by Trump?
Armenia ‘to extend life of its 1970s Metsamor nuclear power plant after 2026’
OUTLOOK 2021 Armenia
COMMENT: Record high debt levels will slow post-coronavirus recovery, threaten some countries' financial stability, says IIF
OUTLOOK 2021 Georgia
Iran’s Khamenei menaces private citizen Trump with image of aircraft shadowing blond golfer
Iran’s technology minister indicted for failing to properly implement internet censorship
No US move to rejoin Iran nuclear deal imminent, say Biden national security nominees
TEHRAN BLOG: Will Biden bet on a quick return to the Iran nuclear deal?
Central Asia vaccination plans underwhelm, but governments look unruffled
Fears of authoritarianism as Kyrgyz populist wins landslide and backing for ‘Khanstitution’
Mongolia's PM quits amid protests over treatment of mother with coronavirus and newborn baby
Mongolia's winter dzud set to be one of most extreme on record says Red Cross
Mongolian coal exports to China paralysed as Beijing demands virus testing of truck drivers
Mongolia fears economic damage as country faces up to its first local transmissions of coronavirus
OUTLOOK 2021 Tajikistan
OUTLOOK 2021 Turkmenistan
Turkmenistan: How the Grinch stole New Year
COMMENT: Uzbekistan is being transformed, but where are the democratic reforms?
Download the pdf version
Sixty-five-year-old Katalin Kariko, the senior vice president at BioNTech, left Hungary in 1985 with a few hundred dollars in her pocket after being fired from her first workplace. With fellow researchers in the US, she discovered the importance of mRNA, which serves as the basis for ongoing COVID-19 vaccine developments. She is listed as one of the potential candidates for the Nobel Prize.
Kariko grew up in Kisujszallas, a rural town of 12,000 in the centre of the Great Plain. Her home town is not far from the UNESCO World Heritage Site Hortobagy Puszta, known for its beautiful natural landscape and exceptional horsemen, the blue-clad "Hungarian cowboys".
She graduated in biology from the University of Szeged. As a young researcher, she received an academic scholarship and her first assignment at the Biological Research Centre of the Hungarian Academy of Sciences was about the synthesis of an antiviral molecule.
Her first job was in Szeged, the southern Hungarian town near the Serbian border, where Albert Szent-Gyorgyi first isolated vitamin C from parika (Capsicum annuum), which earned him the Nobel Prize in 1937.
After earning her PhD, Kariko continued her research and postdoctoral studies at the Institute of Biochemistry in Hungary.
In 1985, on her 30th birthday, she received the pink slip after the research institute cut costs and reduced staff.
In the same year, she decided to leave Hungary for good with her daughter, buying a one-way ticket to the United States. They had no family or friends in the country.
Kariko recalls that she had collected all the foreign currency she could, $50 for each family member. Knowing this would not be enough to start a new life, the family sold their popular Russian-made Lada car. Then they exchanged the money on the black market and sewed it into a teddy bear then boarded a plane to the United States.
She had applied for scholarships in Western Europe but without success. She began work for the Temple University Department of Biochemistry.
Experimentation with mRNA
In 1989, she moved on to the University of Pennsylvania (UPenn), where she had spent the next 24 years doing research.
As a young a biochemical researcher, she discovered the importance of mRNA. The researcher explained the principle of mRNA-based technology in an interview with Magyar Nemzet as follows:
"My first mRNA application was rejected, but I was not discouraged as the results got better and better over time. In 1997, Drew Weissman received a job as an immunologist at UPenn. He wanted to make an HIV vaccine. He tried DNA, but it didn't work. I brought up my mRNA research to him, and we started working together. To our surprise, the synthesised mRNAs activated immune cells. At the time, it seemed that such mRNA might be ideal for a vaccine, but I wanted to use mRNA for therapy. Finally, I replaced one of the four building blocks of mRNA, uridine, with its modified version, pseudouridine, which is often found in the RNA of our cells, and Drew showed that such mRNA is silent, that is, it does not activate immune cells. To our surprise, such a silent mRNA worked better in a vaccine," she said.
The university has patented the method which came to be called Karinko-Weissman after the two researchers, and serves as the basis for the development of many COVID-19 vaccines.
Two of the world’s leading biotechnology companies, BioNTech and Moderna, acquired the patent rights from a third company after university sold the right of use. German BioNTech offered Karinko a job in 2013. She now is deputy VP of the company that employs 1,500 and teamed up with Pfizer to develop the world's first COVID-19 vaccine.
Nobel Prize aspirations
Karinko recalled to Magyar Nemzet that her mother used to follow the news attentively in the weeks prior to the announcement of the Nobel Prize candidates.
She would always say that one day my girl will get it, Kariko said. But then she told her that "mum, I couldn't even get a scholarship, let alone a Nobel Prize!"
"I haven't thought about it since the important thing for me is that as many people get vaccinated as possible," she emphasised
In the scientific world Kariko is now considered to be a favourite candidate for the Nobel Prize for her groundbreaking work behind the development of the vaccine.
Hungarians have won 13 Nobel Prizes since 1905, which puts the country of 9.8mn 13th globally in terms of Nobel laureates per capita and ninth when countries with at least 10 Nobel laureates are counted.
The brain drain of Hungarian scientists is particularly evident as 11 of the 13 received the distinction as nationals of other countries and only two of them when living in Hungary, including writer Imre Kertesz and Albert Szent-Gyorgyi.
Kariko would be the 12th Hungarian to earn the coveted prize abroad.
here to continue reading this article
and 5 more for free or purchase
12 months full website access including
the bne Magazine for just $250/year.
Register to read the bne monthly magazine for
Password could contain only
and have 8-20 symbols length.
Please complete your registration by confirming your
A confirmation email has been sent to the email
address you provided.
can't be empty.
No user with
this email address.
Access recovery request has expired, or you are using
the wrong recovery token. Please, try again.
Access recover request has expired.
Please, try again.
To continue viewing our content you need to complete
the registration process.
Please look for an email that was sent to
with the subject line
"Confirmation bne IntelliNews access". This email will have
instructions on how to complete registration
process. Please check in your "Junk" folder in
case this communication was misdirected in your
If you have any questions please contact us at firstname.lastname@example.org
Sorry, but you have used all your free articles fro
this month for bne IntelliNews. Subscribe
to continue reading for only $119 per year.
Your subscription includes:
For the meantime we are also offering a free
digital weekly newspaper to subscribers to
the online package.
Click here for more subscription options,
including to the print version of our
flagship monthly magazine:
Take a trial to our premium daily news
service aimed at professional investors that
covers the 30 countries of emerging
For any other enquiries about our
products or corporate discounts please
contact us at
If you no longer wish to receive
Magazine annual print
Website & Archive
Combined package: web
access & magazine print
Take a trial to our premium daily news service
aimed at professional investors that
covers the 30 countries of emerging Europe: